LincRNA discovery could lead to targeted treatments

Photo/Shutterstock
DNA genome lincRNA

Our genetic code includes more than 15,000 specific sections that can be made into molecules called lincRNAs. Some of these sections can occur in coiled-up sections of our genome called topologically associating domains, or TADs. 

LincRNAs derived from TADs appear to act as markers indicating the specific kind of tissue they are within. When something is wrong in these tissues, the markers could help with targeted medical interventions. The team that discovered this novel feature has outlined a way to apply this idea to different diseases, and demonstrated it with a heart disease known as hypertrophic cardiomyopathy.

Diseases can affect very specific tissues in our bodies, but current treatments are often indiscriminate in the regions they impact. For this reason, there is a lot of research in the field of medicine towards more specifically targeted treatments. One avenue of research lies in the exploration of relatively recently discovered sections of the genetic code called long intergenic noncoding RNAs, or lincRNAs. The regions on our genome where lincRNAs are copied, or transcribed from, which were once referred to as junk DNA, but a growing body of research suggests these are anything but junk.

“Lately, I felt driven to uncover what made lincRNA different from the more familiar messenger RNA, which is used to make, or express proteins,” said Yu Hamba from the Tsunoda Lab at the University of Tokyo’s Department of Biological Sciences. 

igure 2
LincRNAs in our genome. The genome can be thought of as a long string of genetic information, in which some sections are coiled up into structures called TADs. Within these sections, some subsections transcribed into lincRNAs can indicate the specific tissues they’re within. When these markers show something abnormal, it might in turn indicate if that specific tissue is suffering from a disease. Image/Hamba et al

LincRNA controls biological processes

“I wanted to comprehensively describe the mechanism that explains the difference in specificity of expression between the types of RNA. Whereas messenger RNAs necessarily synthesize proteins, lincRNAs can function without making proteins and seemed far more specific about what they do express. Through expression of different molecules, lincRNAs control many different biological processes, such as certain gene activities, and when expression goes wrong, it could indicate the presence of disease.”

Hamba and her team explored the way some of the 15,000 known lincRNAs were expressed. Their findings confirmed earlier observations that lincRNA expressions were far more dependent on the tissues that contained them, than messenger RNA expressions. But more interestingly, the researchers also discovered that this specificity was further enhanced by where on the genome the particular sections of lincRNA came from. 

LincRNAs transcribed from coiled-up TADs were far more likely to yield tissue-specific expressions than lincRNAs from outside these regions.

“Armed with the knowledge of where to look for these highly tissue-specific lincRNA markers, we propose an analytical framework for interpreting properties of lincRNA as indicators for different tissues,” said Hamba. 

“As an experiment, we already applied our framework to the heart disease hypertrophic cardiomyopathy (in which the heart muscle thickens) and found what causes the abnormal expression of the protein keratin which leads to the disease. It’s my hope that we can now explore this area further and find some of the underlying abnormal expression products that might lead to things like tumors.”

Partnering 2030: The Biotech Perspective 2023

Download Inpart’s latest report revealing the priorities of out-licensers worldwide.

Newsletter Signup - Under Article / In Page

"*" indicates required fields

Subscribe to our newsletter to get the latest biotech news!

Name*
This field is for validation purposes and should be left unchanged.
Labiotech.eu

Suggested Articles

Show More